Congress·In Committee·S. 2062

RAPID Reserve Act

Senate Bill Would Require 6-Month Drug Stockpiles to Prevent Critical Shortages

Jun 12, 2025·View on Congress.gov·Read full text

Part of: Congress Proposes $500M for National Drug Reserves to Combat Shortages

This bill is one vehicle in a longer effort. See the full story across every version.View effort →

StalledNext up: A senate committeeNo action in 13 months

A senate committee must act next: committee consideration.

Legislative Progress

Senate

No action since June 2025

House

President

Law

How we got here

This bill’s path across every version that has carried it.

Reintroduced
Reintroduced from S. 2510 (118th), which died when its Congress ended.
S. 2510 (118th) →

Key Points

Congress would have Health and Human Services pay drug makers and partners to keep rolling reserves of certain “critical” drugs and ingredients.
Companies would generally need to keep about a 6-month supply of both the drug ingredient and the finished drug, and replace it with newly made stock regularly.
In a shortage or emergency, Health and Human Services could direct production and could direct where some of the ingredient stockpile is sent to help make more finished medicine.
The program would prefer U.S.-based manufacturing and U.S.-sourced materials (or from certain partner countries) to reduce reliance on fragile supply chains.
The bill authorizes $500 million for 2026 and requires regular reports to Congress on which drugs are covered and how well the program works.

HealthcarePrescription DrugsNational Security

Impact Analysis

Personal Impact

How this policy affects specific groups of people

Positive Impacts(2)

Chronic Illness

Helps

Disability Benefits

Helps

Milestones

2 milestones2 actions

Jun 12, 2025Senate

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.

Jun 12, 2025

Introduced in Senate

The bill was officially filed and given a number. It now enters the legislative queue.

Related News

3 articles

Fierce Pharma·Jun 17, 2025

Senators bring back bill to bolster US pharma supply chain by awarding contracts to domestic producers

The RAPID Reserve Act would require HHS to award contracts to U.S.-based drugmakers to maintain 6-month reserves of critical medications and ingredients. The bipartisan bill aims to address chronic drug shortages and reduce national security threats from overreliance on foreign suppliers.

Center

Becker's Hospital Review·Jun 17, 2025

Senate bill aims to rebuild drug manufacturing infrastructure: 3 notes

Reintroduced by a bipartisan group of senators, the RAPID Reserve Act directs HHS to contract with manufacturers for 6-month stockpiles of essential generic drugs. The bill seeks to address chronic shortages that have left some medications unavailable for over a decade.

Center

Fierce Pharma·Dec 2, 2025

Lawmakers dig in on biopharma manufacturing with bill proposing US center of excellence

Lawmakers highlighted the RAPID Reserve Act as a key legislative component in a broader strategy to improve pharmaceutical preparedness. The bill focuses on building domestic reserves and surge capacity to prevent national security threats from drug shortages.

Center

No votes or related bills recorded for this bill yet.